Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.
Search results for:

alglucosidase alfa

alglucosidase alfa
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Lumizyme POWDER FOR INJECTION, INTRAVENOUS 50 mg      
Myozyme POWDER FOR INJECTION, INTRAVENOUS 50 mg      


Comments:

Both classified as restricted to outpatient, if case arises notify pharmacy administration for approval, each case will be evaluated on an individual basis, referral to a treatment center would be considered.

Lumizyme approved for a specific patient to receive at Outpatient Medical on a longterm basis.


Reviewed: June 27, 2006 (Myozyme), September 29, 2010 and September 25, 2013 (Lumizyme)


Last updated: Dec. 28, 2017







This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.